NCT06719219 A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus. Status COMPLETED Phase PHASE1
NCT06719141 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) Status RECRUITING Phase PHASE3
NCT06718751 Tranexamic Acid Therapy For The Treatment of Subdural Hematomas Status NOT_YET_RECRUITING Phase PHASE2
NCT06718101 A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06717698 A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease Status RECRUITING Phase PHASE2
NCT06717438 Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS]) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06717425 A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity Status COMPLETED Phase PHASE2
NCT06717152 Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease Status COMPLETED Phase PHASE3
NCT06717074 A Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of RBD4059 in Participants With Stable Coronary Artery Disease Status COMPLETED Phase PHASE2
NCT06716905 Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT06716879 A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of a Single Dose of Donzakimig in Healthy Chinese and Japanese Participants Status COMPLETED Phase PHASE1
NCT06716281 Efficacy and Safety of IxCell hUC-MSC-O in Patients With Knee Osteoarthritis Status RECRUITING Phase PHASE3
NCT06716021 ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3 Status NOT_YET_RECRUITING Phase PHASE3
NCT06715891 Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of ARVI in Children Aged 3-12 Years Status RECRUITING Phase PHASE3
NCT06715319 Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis Status COMPLETED Phase PHASE3
NCT06714825 Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects Status COMPLETED Phase PHASE1
NCT06714513 ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 Status RECRUITING Phase PHASE1